AZNH news

AstraZeneca PLC ADRhedged · Pharmaceuticals · United Kingdom

Stories about this fund's companies, ranked by fund weight and recency. Times are local.

wallstreet:online · 28 Oct 2026, 12:05 UTC
AstraZeneca and Mark-Paul Gosselaar Launch Meet Your Mark to Raise Awareness of Cancer Biomarker Testing
99.4% of AZNH
The Manila times · 28 Oct 2026, 11:31 UTC
Micron Biomedical Appoints Anand Subramony, Ph.D., as Executive Vice President, Global Product Development and Combination Product Commercialization
99.4% of AZNH
Investing.com · 27 Oct 2026, 17:27 UTC
Stock Market News - Investing.com
99.4% of AZNH
Quartz · 27 Oct 2026, 17:15 UTC
AstraZeneca might develop cancer vaccines, CEO Pascal Soriot says
99.4% of AZNH
Where to buy AZNH
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
Market Screener · 27 Oct 2026, 16:47 UTC
Daiichi Sankyo And AstraZeneca Receive European Union Approval For Enhertu As Adjuvant Treatment For Patients With Residual Disease After Neoadjuvant Treatment For HER2 Positive Early Breast Cancer
99.4% of AZNH
Bloomberg Business · 27 Oct 2026, 16:44 UTC
AstraZeneca May Enter Cancer Vaccine Development, CEO Says
99.4% of AZNH
Where to buy AZNH
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
RTTNews · 27 Oct 2026, 10:06 UTC
AstraZeneca, Daiichi Sankyo's Enhertu Wins First EU Approval In Early Breast Cancer Setting
99.4% of AZNH
RTTNews · 27 Oct 2026, 09:40 UTC
AstraZeneca Names Onco360 National Speciality Pharmacy Partner For Zegfrovy
99.4% of AZNH
Market Screener · 27 Oct 2026, 08:56 UTC
AstraZeneca's Enhertu receives EU approval
99.4% of AZNH
Morningstar · 27 Oct 2026, 08:04 UTC
AstraZeneca, Daiichi Sankyo Drug Gets EU Nod in Early-Stage Breast Cancer
99.4% of AZNH
Market Screener · 27 Oct 2026, 06:09 UTC
Timeline Delayed for Innate Pharma and AstraZeneca Trial
99.4% of AZNH
Investing.com · 27 Oct 2026, 06:04 UTC
AstraZeneca delays PACIFIC-9 lung cancer trial data to H1 2027 By Investing.com
99.4% of AZNH
wallstreet:online · 27 Oct 2026, 06:00 UTC
PACIFIC-9 Phase 3 Trial Readout Timing Updated to H1 2027
99.4% of AZNH
Financial Post · 27 Oct 2026, 00:00 UTC
Breast Cancer Canada and AstraZeneca Canada Advance Next-Generation Survivorship Research
99.4% of AZNH
Benzinga · 26 Oct 2026, 13:23 UTC
Amgen, AstraZeneca Drug Combo Shows Promising Survival Results in Tough-To-Treat Lung Cancer - Amgen (NAS
99.4% of AZNH
Quartz · 26 Oct 2026, 12:36 UTC
Amgen Imdelltra combo cut death risk by 58% in lung cancer trial
99.4% of AZNH
Quartz · 26 Oct 2026, 11:56 UTC
AstraZeneca readies gastric cancer drug Sone-Ve for regulatory filing
99.4% of AZNH
24/7 Wall St. · 26 Oct 2026, 11:45 UTC
Is AstraZeneca's Pipeline Fuel Enough to Spark a Post-Earnings Breakout on Oct. 30?
99.4% of AZNH
RTTNews · 26 Oct 2026, 11:44 UTC
AstraZeneca's Sone-Ve Cuts Death Risk By 42% In Advanced Gastric Cancer Trial; Stock Up
99.4% of AZNH
The Motley Fool · 26 Oct 2026, 11:30 UTC
Breakfast News: Science Strikes Back at Cancer
99.4% of AZNH

AZNH news

Where to buy AZNH

Where to buy AZNH